Haematologica

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort

The early expansion of anergic NKG2A(pos)/CD56(dim)/CD16(neg) natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

Emerging disease-modifying therapies for sickle cell disease

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy

The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia